Last quarter, Abbott sold its optics division (Abbott Medical Optics) and used that money to increase sales and advertising.
But predicted EPS only increased by 0.05, from 0.55 to 0.60, with a consensus of 11 estimates. What's with that?
Also, Alere is merging with Abbott. The two biggest POC manufacturers are merging together. Isn't there laws against monopolies?
Submitted July 11, 2017 at 06:23PM by Nullrasa